研究用抗体和试剂市场－全球产业规模、份额、趋势、机会和预测，依产品、技术、应用、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球研究用抗体和试剂市场规模为106.9亿美元，预计2030年将以5.96%的复合年增长率成长至151.3亿美元。研究用抗体是经过基因工程改造或天然提取的蛋白质，能够特异性地结合标靶分子；而试剂则涵盖其他重要的化学和生物物质，这些物质是各种实验室检测中不可或缺的工具，用于检测、定量和分离生物分子，广泛应用于蛋白质组学、基因组学和药物研发等领域。市场成长的主要驱动因素包括：全球生命科学研究投资的不断增加、慢性疾病盛行率的上升（需要广泛的生物医学研究）以及产学合作的加强。

主要市场驱动因素

全球研究用抗体和试剂市场主要受益于生命科学研发投入的不断增长以及基因组学和蛋白​​质组学研究的进步。政府机构和製药公司的大力投入是这一成长的重要支撑，也推动了对专业研究工具的需求。

主要市场挑战

抗体品质和批间重复性方面的持续担忧，严重阻碍了全球科研抗体和试剂市场的成长。这项挑战直接影响了科学研究的可靠性，因为研究人员经常会遇到产品性能的差异，从而影响实验结果。

主要市场趋势

重组抗体和工程抗体的快速发展显着影响全球科研抗体和试剂市场，与传统抗体相比，它们具有更高的特异性、可重复性和通用性。这些先进抗体最大限度地减少了批次间差异，并能够在复杂的生物系统中实现更精准的靶向，这对于复杂的科研应用至关重要。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球研究用抗体与试剂市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 副产品（抗体、试剂）
  • 依技术分类（蛋白质印迹法、流式细胞仪、酵素连结免疫吸附试验）
  • 依应用领域（蛋白质体学、基因体学）
  • 依最终用户（製药、生技、合约研究组织）划分
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美研究用抗体与试剂市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲研究用抗体与试剂市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区研究用抗体和试剂市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲研究用抗体和试剂市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲研究用抗体与试剂市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球科学研究抗体与试剂市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Abcam Plc.
• Thermo Fischer Scientific, Inc.
• Merck KGaA
• F. Hoffmann-La Roche Ltd.
• Bio-Rad laboratories, Inc.
• Agilent Technologies, Inc.
• Danaher corporation
• Lonza Group Ltd.
• Genscript Biotech Corporation

第十六章：策略建议

第17章调查会社について・免责事项

The Global Research Antibodies and Reagents Market, valued at USD 10.69 Billion in 2024, is projected to experience a CAGR of 5.96% to reach USD 15.13 Billion by 2030. Research antibodies are proteins engineered or naturally derived to specifically bind target molecules, while reagents encompass other critical chemical and biological substances integral to diverse laboratory assays, serving as indispensable tools for detecting, quantifying, and isolating biomolecules in applications such as proteomics, genomics, and drug discovery. The market's growth is primarily driven by increasing global investment in life science research, the expanding prevalence of chronic diseases necessitating extensive biomedical investigation, and robust industry-academia collaborations.

Key Market Drivers

The global research antibodies and reagents market is significantly propelled by increasing life sciences research and development investments and advancements in genomics and proteomics research. Robust funding commitments from governmental bodies and pharmaceutical companies underpin a substantial portion of this growth, fueling the demand for specialized research tools.

Key Market Challenges

The persistent concern regarding antibody quality and batch-to-batch reproducibility represents a significant impediment to the growth of the Global Research Antibodies and Reagents Market. This challenge directly undermines the reliability of scientific investigations, as researchers frequently encounter variations in product performance that compromise experimental outcomes. Consequently, a considerable portion of research time and resources is diverted to extensive, often redundant, validation processes for reagents before reliable results can be obtained. This ongoing need for in-house validation diminishes efficiency and increases operational costs for research laboratories.

Key Market Trends

The growing development of recombinant and engineered antibodies significantly influences the global research antibodies and reagents market by offering enhanced specificity, reproducibility, and versatility compared to traditional antibody formats. These advanced antibodies minimize batch-to-batch variation and enable more precise targeting in complex biological systems, which is crucial for sophisticated research applications.

Key Market Players

• Abcam Plc.
• Thermo Fischer Scientific, Inc.
• Merck KGaA
• F. Hoffmann-La Roche Ltd.
• Bio-Rad laboratories, Inc.
• Agilent Technologies, Inc.
• Danaher corporation
• Lonza Group Ltd.
• Genscript Biotech Corporation

Report Scope:

In this report, the Global Research Antibodies and Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Research Antibodies and Reagents Market, By Product:

• Antibodies
• Reagents

Research Antibodies and Reagents Market, By Technology:

• Western Blot
• Flow Cytometry
• ELISA

Research Antibodies and Reagents Market, By Application:

• Proteomics
• Genomics

Research Antibodies and Reagents Market, By End User:

• Pharma
• Biotech
• CRO

Research Antibodies and Reagents Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Research Antibodies and Reagents Market.

Available Customizations:

Global Research Antibodies and Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Research Antibodies and Reagents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Antibodies, Reagents)
  • 5.2.2. By Technology (Western Blot, Flow Cytometry, ELISA)
  • 5.2.3. By Application (Proteomics, Genomics)
  • 5.2.4. By End User (Pharma, Biotech, CRO)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Research Antibodies and Reagents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Research Antibodies and Reagents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Research Antibodies and Reagents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Research Antibodies and Reagents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Research Antibodies and Reagents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Research Antibodies and Reagents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Research Antibodies and Reagents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Research Antibodies and Reagents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Research Antibodies and Reagents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Research Antibodies and Reagents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Research Antibodies and Reagents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Research Antibodies and Reagents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Research Antibodies and Reagents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Research Antibodies and Reagents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Research Antibodies and Reagents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Research Antibodies and Reagents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Research Antibodies and Reagents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Research Antibodies and Reagents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Research Antibodies and Reagents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Research Antibodies and Reagents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Research Antibodies and Reagents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Research Antibodies and Reagents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Research Antibodies and Reagents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Research Antibodies and Reagents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Research Antibodies and Reagents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abcam Plc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fischer Scientific, Inc.
• 15.3. Merck KGaA
• 15.4. F. Hoffmann-La Roche Ltd.
• 15.5. Bio-Rad laboratories, Inc.
• 15.6. Agilent Technologies, Inc.
• 15.7. Danaher corporation
• 15.8. Lonza Group Ltd.
• 15.9. Genscript Biotech Corporation

16. Strategic Recommendations

17. About Us & Disclaimer